| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.24 | 2e-13 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.23 | 1e-11 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.22 | 2e-09 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-08 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.19 | 4e-08 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.16 | 5e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-06 |